Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 96

Sort by

Sort Order Select

Journal Articles

Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Improved Prognosis for Advanced NK/T Cell Lymphoma

Zhihui Li, Xianxuan Wang, Keyan Yang, Lei Wang, Xiaopei Wen, Jingjing Wang, Jing Li, Yanzhi Song, Yongqiang Zhao, Qinlong Zheng, Tong Wu

Blood (2024) 144 (Supplement 1): 599.

https://doi.org/10.1182/blood-2024-200684

Published: 2024

Journal Articles

Double-Hit/Triple-Hit Myeloma: An Adverse Prognostic Factor That Can be Overcome By Minimal Residual Disease Negativity

Yang Yang, Wenjing Wang, Liang Ren, Yawen Wang, Aziguli Maihemaiti, Tianwei Lan, Chi Zhou, Panpan Li, Pu Wang, Jing Li, Jiadai Xu, Tianhong Xu, Fei-fei Chen, Peng Liu

Blood (2024) 144 (Supplement 1): 6956.

https://doi.org/10.1182/blood-2024-207788

Published: 2024

Journal Articles

Differentiation Route Generates Functional Biased Platelets and Responses Distinctly to Varying Physiological Demands

Jingkun Liu, Liping Wang, Yanxun Su, Kunying Chen, Jing-Jing Li, Bo O. Zhou, Yueying Li, Qian-Fei Wang

Blood (2024) 144 (Supplement 1): 426.

https://doi.org/10.1182/blood-2024-204569

Published: 2024

Journal Articles

Assessing Cytogenetic Abnormalities in Myeloma: A Comparative Study of Hi-C, Karyotyping, and iFISH Techniques

Jing Li, Yang Yang, Chenqi Yu, Yuxia Yang, Peng Liu

Blood (2024) 144 (Supplement 1): 4700.

https://doi.org/10.1182/blood-2024-207188

Published: 2024

Journal Articles

Tandem CAR-T-Cell Therapy Targeting CD5 and CD7: Facilitating Condition-Free Engraftment of Epitope-Edited Allogeneic HSCs

Guo-Ling Wang, Ting Wang, Jing-Li Han, Li-Xin Wu, Xuan-Zhong Chen, Zhuo-Yu An, Chen-Cong Wang, Peng Zhao, Lu-Lu Wang, Meng-Tong Zang, Wei Zheng, Hai-Xia Fu, Jia Feng, Hong-Yu Zhang, Xiaohui Zhang

Blood (2024) 144 (Supplement 1): 2041.

https://doi.org/10.1182/blood-2024-208043

Published: 2024

Journal Articles

Comparison of Ixazomib, Lenalidomide Plus Dexamethasone (IRd) and Bortezomib, Lenalidomide Plus Dexamethasone (VRd) in Newly Diagnosed Multiple Myeloma in China

Wenjing Wang, Jing Li, Mengyuan Li, Xiao He, LI Bao, Xiaoqiong Tang, Hua Xue, Jianmei Xu, Liye Zhong, Peng Liu

Blood (2024) 144 (Supplement 1): 5159.

https://doi.org/10.1182/blood-2024-207888

Published: 2024

Journal Articles

IL-2-Inducible T Cell Kinase Deficiency Enables Development of Sustainable Chimeric Antigen Receptor T Cell Therapy

Blood (2024) 144 (Supplement 1): 3411.

https://doi.org/10.1182/blood-2024-201942

Published: 2024

Journal Articles

Influence of Somatic and Germline Gene Variants on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies

Zhihui Li, Keyan Yang, Lei Wang, Xianxuan Wang, Xiaopei Wen, Jingjing Wang, Jing Li, Yanzhi Song, Yongqiang Zhao, Qinlong Zheng, Tong Wu

Blood (2024) 144 (Supplement 1): 4922.

https://doi.org/10.1182/blood-2024-200716

Published: 2024

Journal Articles

Clinical Implication of Minimal Residual Disease By Multiparameter Flow Cytometry in Light Chain Amyloidosis

Tianhong Xu, Jing Li, Yang Yang, Wenjing Wang, Pu Wang, Chenqi Yu, Peng Liu

Blood (2023) 142 (Supplement 1): 6770.

https://doi.org/10.1182/blood-2023-184754

Published: 2023

Journal Articles

The China Monoclonal Gammopathy Screening Project in First-Degree Relatives of Patients with Multiple Myeloma (CHAPERONE) –a Multicenter Screening Study

Jing Li, Peng Liu

Blood (2023) 142 (Supplement 1): 6776.

https://doi.org/10.1182/blood-2023-187944

Published: 2023

Journal Articles

Clinical Characterization of Hepatic Light Chain Amyloidosis in the Chinese Population: A Single-Center Retrospective Analysis

Chen Chen, Chenqi Yu, Jing Li, Weiguang Wang, Zhimei Wang, Lu-Ya Cheng, Fei-fei Chen, Jiadai Xu, Tianhong Xu, Yang Yang, Wenjing Wang, Pu Wang, Peng Liu

Blood (2023) 142 (Supplement 1): 6745.

https://doi.org/10.1182/blood-2023-186600

Published: 2023

Journal Articles

Two-Year Follow-up Results of C-CAR066, a Novel Anti-CD20 Chimeric Antigen Receptor Cell Therapy (CAR-T) in Relapsed or Refractory (r/r) Large B-Cell Lymphoma (LBCL) Patients after Failure of CD19 CAR-T Therapy

Ping Li, Wei Liu, Shiguang Ye, Lili Zhou, Judy Zhu, Jiaqi Huang, Jing Li, Shigui Zhu, Chengxiao Zheng, Kevin Zhu, Xin Yao, Hui Wan, Yihong Yao, Aibin Liang, Dehui Zou

Blood (2023) 142 (Supplement 1): 2115.

https://doi.org/10.1182/blood-2023-181527

Published: 2023

Journal Articles

As Fast As We Can: Rational Design of Rapid Chimeric Antigen Receptor T Cell Manufacturing

Pengfei Jiang, Shih-Ting Cao, Haiying Wang, Qinghui Xiong, Mingyuan Gu, Chengbing Fu, Xiu Li, Mian Zhang, Na Li, Jing Li, Xin Xu, Yiwei Gong

Blood (2023) 142 (Supplement 1): 3453.

https://doi.org/10.1182/blood-2023-188144

Published: 2023

Journal Articles

A Comparative Study of Clinical Characteristics, Cytogenetic Abnormalities and Outcomes Among Multiple Myeloma, Primary Light-Chain Amyloidosis and Multiple Myeloma with Concurrent AL Amyloidosis

Chenqi Yu, Jing Li, Tianhong Xu, Wenjing Wang, Pu Wang, Yang Yang, Peng Liu

Blood (2023) 142 (Supplement 1): 2032.

https://doi.org/10.1182/blood-2023-188350

Published: 2023

Journal Articles

C-CAR039, a Novel Anti-CD20/CD19 Bi-Specific CAR T-Cell Therapy Shows Deep and Durable Clinical Benefits in Patients with Relapsed or Refractory (r/r) B-Cell Non-Hodgkin Lymphoma (B-NHL) in Long Term Follow up

Blood (2023) 142 (Supplement 1): 1025.

https://doi.org/10.1182/blood-2023-182817

Published: 2023

Journal Articles

Oral Realgar- Indigo Naturalis Formula Versus Intravenous Arsenic Trioxide for Non-High-Risk Patients with Acute Promyelocytic Leukemia: Interim Results of a Multicenter Randomized Controlled Trial APL16

Huaiyu Wang, Shu Chen, Xiaojuan Zhang, Xinhua Lu, Sha Gong, David Wald, Haitao Zhang, Jing Li

Blood (2022) 140 (Supplement 1): 2014–2015.

https://doi.org/10.1182/blood-2022-166635

Published: 2022

Journal Articles

Update on the Outcome of M-Protein Screening Program of Multiple Myeloma in China: A 7-Year Cohort Study

Wenjing Wang, Jing Li, Yang Yang, Feifei Chen, Tianhong Xu, Pu Wang, Yawen Wang, Aziguli Maihemaiti, Liang Ren, Peng Liu

Blood (2022) 140 (Supplement 1): 10097–10098.

https://doi.org/10.1182/blood-2022-168200

Published: 2022

Journal Articles

Single-Cell Analyses of Immune Microenvironment Informs Potential Benefits of Dual Macrophage-Targeted Therapy in Multiple Myeloma

Jing Li, Yang Yang, Wenjing Wang, Jiadai Xu, Peng Liu

Blood (2022) 140 (Supplement 1): 4255–4256.

https://doi.org/10.1182/blood-2022-166274

Published: 2022

Journal Articles

Profiles of Germline Predisposition Gene Variants in Hematologic Disorders and Its Impact on Prognosis of Allogeneic Hematopoietic Stem Cell Transplantation

Zhihui Li, Keyan Yang, Qinlong Zheng, Xianxuan Wang, Fan Wu, Jing Li, Xiaopei Wen, Caiyan Zhang, Jingjing Wang, Yanzhi Song, Yongqiang Zhao, Tong Wu

Blood (2022) 140 (Supplement 1): 7693–7694.

https://doi.org/10.1182/blood-2022-166695

Published: 2022

Journal Articles

Homoharringtonine-Based Induction Regimens Combined with ATRA-Based Maintenance in Chinese Pediatric AML: A Report from the Cclg-AML 2015 Protocol Study

Blood (2022) 140 (Supplement 1): 3189–3191.

https://doi.org/10.1182/blood-2022-165737

Published: 2022

NARROW

Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Improved Prognosis for Advanced NK/T Cell Lymphoma

Double-Hit/Triple-Hit Myeloma: An Adverse Prognostic Factor That Can be Overcome By Minimal Residual Disease Negativity

Differentiation Route Generates Functional Biased Platelets and Responses Distinctly to Varying Physiological Demands

Assessing Cytogenetic Abnormalities in Myeloma: A Comparative Study of Hi-C, Karyotyping, and iFISH Techniques

Tandem CAR-T-Cell Therapy Targeting CD5 and CD7: Facilitating Condition-Free Engraftment of Epitope-Edited Allogeneic HSCs

Comparison of Ixazomib, Lenalidomide Plus Dexamethasone (IRd) and Bortezomib, Lenalidomide Plus Dexamethasone (VRd) in Newly Diagnosed Multiple Myeloma in China

IL-2-Inducible T Cell Kinase Deficiency Enables Development of Sustainable Chimeric Antigen Receptor T Cell Therapy

Influence of Somatic and Germline Gene Variants on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies

Clinical Implication of Minimal Residual Disease By Multiparameter Flow Cytometry in Light Chain Amyloidosis

The China Monoclonal Gammopathy Screening Project in First-Degree Relatives of Patients with Multiple Myeloma (CHAPERONE) –a Multicenter Screening Study

Clinical Characterization of Hepatic Light Chain Amyloidosis in the Chinese Population: A Single-Center Retrospective Analysis

Two-Year Follow-up Results of C-CAR066, a Novel Anti-CD20 Chimeric Antigen Receptor Cell Therapy (CAR-T) in Relapsed or Refractory (r/r) Large B-Cell Lymphoma (LBCL) Patients after Failure of CD19 CAR-T Therapy

As Fast As We Can: Rational Design of Rapid Chimeric Antigen Receptor T Cell Manufacturing

A Comparative Study of Clinical Characteristics, Cytogenetic Abnormalities and Outcomes Among Multiple Myeloma, Primary Light-Chain Amyloidosis and Multiple Myeloma with Concurrent AL Amyloidosis

C-CAR039, a Novel Anti-CD20/CD19 Bi-Specific CAR T-Cell Therapy Shows Deep and Durable Clinical Benefits in Patients with Relapsed or Refractory (r/r) B-Cell Non-Hodgkin Lymphoma (B-NHL) in Long Term Follow up

Oral Realgar- Indigo Naturalis Formula Versus Intravenous Arsenic Trioxide for Non-High-Risk Patients with Acute Promyelocytic Leukemia: Interim Results of a Multicenter Randomized Controlled Trial APL16

Update on the Outcome of M-Protein Screening Program of Multiple Myeloma in China: A 7-Year Cohort Study

Single-Cell Analyses of Immune Microenvironment Informs Potential Benefits of Dual Macrophage-Targeted Therapy in Multiple Myeloma

Profiles of Germline Predisposition Gene Variants in Hematologic Disorders and Its Impact on Prognosis of Allogeneic Hematopoietic Stem Cell Transplantation

Homoharringtonine-Based Induction Regimens Combined with ATRA-Based Maintenance in Chinese Pediatric AML: A Report from the Cclg-AML 2015 Protocol Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only